How Mobocertinib can Save You Time, Stress, and Money.
Pharmacological inhibition of the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; generally known as FRAP-relevant protein (FRP1)) has emerged being a promising strategy for cancer remedy that exploits artificial lethal interactions with proteins associated with DNA destruction fix, overcomes resistance to other therapi